Session 1.7: Mitochondria. Therapeutical strategies in mitochondrial dysfunction
Tracks
MR11
Friday, June 7, 2024 |
11:00 AM - 12:30 PM |
MR11 |
Speaker
Prof. Patrick Yu-Wai-Man
Professor of Ophthalmology
University of Cambridge
OPA1 dominant optic atrophy – from disease mechanisms to novel therapies
11:00 AM - 11:30 AM
Dr. Ramon Martí
Group Leader
Vall d'Hebron Research Institute (VHIR)
Nucleotide metabolism as a therapeutic target for mtDNA maintenance disorders
11:30 AM - 12:00 PM
Mrs. Carina Magalhães
University Of Coimbra
The mitochondriotropic antioxidant AntiOxBEN2 prevents hepatic steatosis in male and female mice fed with high-fat high-sugar (HFHS) diet
12:00 PM - 12:10 PM
Mr. Débora Mena
CNC-UC - Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.
The mitochondria-targeted antioxidant AntiOxCIN4 mitigates cardiac oxidative/nitrosative stress in the amyotrophic lateral sclerosis SOD1G93A mouse
12:10 PM - 12:20 PM
Francesc J. García García
Postdoctoral Researcher
CELLEX-IDIBAPS Hospital Clínic de Barcelona
Impact of early treatments in oxidative stress and mitochondrial dysfunction of phenylketonuria
12:20 PM - 12:30 PM